Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol prolonged-release randomized withdrawal study in chronic malignant tumor-related pain
2006-004997-28Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in cancer pain (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Responder rate at end of maintenance phase. Started Jan 2007; status: completed.
02
Drugs
tapentadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2006-004997-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004997-28.